NCT05620680View on ClinicalTrials.gov

CD7 CAR-T Cells in T-cell Lymphoma/Leukemia

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2028

Conditions
T Lymphoblastic Leukemia/Lymphoma
Interventions
BIOLOGICAL

CD7 CAR-T cells

patient was subjected to 0.5-2×10\^6 cells/kg of CD7 CAR- T

Trial Locations (1)

518000

RECRUITING

Li Yu, Shenzhen

All Listed Sponsors
lead

Shenzhen University General Hospital

OTHER